Skip to content
10-K

Annual Report

NIKA PHARMACEUTICALS, INC NIKA

0001826466-25-000030

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 10, 2025 1.03B sh
Revenue FY 2024 · Dec 31, 2024 $0
Shares Diluted FY 2024 · Dec 31, 2023 876.09M sh
Operating Cash Flow restated FY 2024 · Dec 31, 2023 −$64.83K
Short Term Debt FY 2024 · Dec 31, 2023 $101.75K
Cash And Equivalents FY 2024 · Dec 31, 2023 $19.6K
Current Liabilities FY 2024 · Dec 31, 2023 $101.75K
Total Liabilities FY 2024 · Dec 31, 2023 $101.75K
Current Assets FY 2024 · Dec 31, 2023 $19.6K
Total Assets FY 2024 · Dec 31, 2023 $19.6K
Eps Diluted FY 2024 · Dec 31, 2023 $0.00
Eps Basic FY 2024 · Dec 31, 2023 $0.00
Sga Expense FY 2024 · Dec 31, 2023 $64.83K
Net Income FY 2024 · Dec 31, 2023 −$64.83K
Operating Income FY 2024 · Dec 31, 2023 −$64.83K
Stockholders Equity FY 2024 · Dec 31, 2022 −$17.32K